Prof Saul Faust, co-study leader at the University of Southampton and a consultant paediatrician, said: “These latest results show that this long-acting antibody is safe and could protect thousands of babies from hospitalisation when used in conditions similar to routine clinical practice. It is really important information for the UK to help decide on options for the future national RSV immunisation programme.”
Trending
- “He had a big impact on the history of film in this country”: Industry pays tribute to Simon Field who has died aged 80 | News
- BFC kondigt voorlopig schema aan
- Theo Leber Joins Dwayne Johnson In Benny Safdie Movie
- European Commission eases penalties linked to methane rules
- ‘Onwards and Sideways,’ With Laura Linney, Rhys Ifans
- Will gold prices extend their record-breaking run?
- Tom Brady, Logan Paul, Ariana Grande and More Hollywood Scoop
- US appeals court decertifies Boeing class action stemming from MAX 9 blowout
